Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
Retired game-keeper Raymond Arthur Evans’ passion for guns landed him in hot water. Nursing home staff even found a pistol in his room.
RSPCA Cymru says it's worried about a rise in reports of pets being poisoned. Here's the charity's advice on how to keep your animals safe.
Brian, 85, and Shirley, 80, plan to pose side by side on the church steps to recreate their cherished black and white wedding photo.